XXII Century Group Inc

22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

$4.62  +0.08 (1.76%)
As of 06/24/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/26/2011
Outstanding shares:  152,566,610
Average volume:  2,664,545
Market cap:   $686,549,745
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    90137F103
ISIN:        US90137F1030
Sedol:      B1FH4T9
Valuation   (See tab for details)
PE ratio:   -33.44
PB ratio:   13.20
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy